Skip to main content
Log in

Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han

  • Original Article
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Idiopathic inflammatory myopathies (IIMs) are autoimmune diseases with an underlying yet undefined genetic component. Recently, phospholipase C-like 1 (PLCL1) has been identified as a potential genetic susceptibility locus for dermatomyositis (DM) in patients of European ancestry. Here, association between PLCL1 polymorphisms and IIMs was investigated in Chinese Han. Genomic DNA was isolated from blood samples (2 mL) collected from Chinese Han (≥18 years) with polymyositis (PM, n = 286) or dermatomyositis (DM, n = 535) and ethnically matched controls (n = 968). Patients and controls were genotyped for five SNPs (rs938929, rs1518364, rs6738825, rs2117339, and rs7572733) previously associated with DM, with the Sequenom MassARRAY system. SNPs rs6738825 and rs7572733 were found to be associated with the development of DM in Chinese Han (P c = 0.015; P c = 0.025, respectively) as well as the risk A allele of rs938929 and T allele of rs1518364 (P c = 0.030; P c = 0.029). None of the five SNPs were associated with PM (all P c > 0.05). The frequency of the two haplotypes of these five SNPs was also significantly different between DM patients and healthy controls. In addition, conditional analysis with rs6738825 revealed that these SNPs were not independent factors contributing to DM. Finally, a novel association between rs6738825 and rs7572733 and DM with complicating interstitial lung disease was observed (ILD; P c = 0.040; P c = 0.030, respectively). A positive association between PLCL1 polymorphisms and DM patients and DM patients with ILD was observed, indicating that PLCL1 might be the susceptibility gene for DM patients in Chinese Han.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991;325:1487–98.

    Article  CAS  PubMed  Google Scholar 

  2. Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol. 1996;9:235–9.

    Article  CAS  PubMed  Google Scholar 

  3. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am. 2002;28:723–41.

    Article  Google Scholar 

  4. Engel AG, Arahata K, Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res Publ Assoc Res Nerv Ment Dis. 1990;68:141–57.

    CAS  PubMed  Google Scholar 

  5. Hilton-Jones D. Inflammatory muscle diseases. Curr Opin Neurol. 2001;14:591–6.

    Article  CAS  PubMed  Google Scholar 

  6. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986;19:112–25.

    Article  CAS  PubMed  Google Scholar 

  7. Chen IJ, Jan WY, Lin CW, Fan KW, Luo SF, Ho HH, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol. 2009;28:639–46.

    Article  PubMed  Google Scholar 

  8. Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26:1647–54.

    Article  PubMed  Google Scholar 

  9. Won HJ, Soon KD, Keun LC, Yoo B, Bum SJ, Kitaichi M, et al. Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med. 2007;101:1761–9.

    Article  Google Scholar 

  10. Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Nihon Rinsho Meneki Gakkai Kaishi. 2007;30:444–54.

    Article  PubMed  Google Scholar 

  11. Chinoy H, Lamb JA, Ollier WE, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther. 2011;13:216.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K, et al. Brief report: association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheumatol. 2012;64:3736–40.

    Article  CAS  Google Scholar 

  13. Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, et al. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis. 2012;71:961–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Hassan AB, Nikitina-Zake L, Sanjeevi CB, Lundberg IE, Padyukov L. Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis. Arthritis Rheumatol. 2004;50:1013–5.

    Article  CAS  Google Scholar 

  15. Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, et al. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheumatol. 2000;43:2368–77.

    Article  CAS  Google Scholar 

  16. Mamyrova G, O’Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, et al. Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheumatol. 2008;58:3941–50.

    Article  CAS  Google Scholar 

  17. Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, et al. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatol (Oxf). 2007;46:1411–6.

    Article  CAS  Google Scholar 

  18. Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, et al. Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK. Ann Rheum Dis. 2007;66:970–3.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Gono T, Kawaguchi Y, Sugiura T, Furuya T, Kawamoto M, Hanaoka M, et al. Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis. Mod Rheumatol. 2010;20:466–70.

    Article  CAS  PubMed  Google Scholar 

  20. Werth VP, Berlin JA, Callen JP, Mick R, Sullivan KE. Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol. 2002;119:1394–9.

    Article  CAS  PubMed  Google Scholar 

  21. Chinoy H, Li CK, Platt H, Fertig N, Varsani H, Gunawardena H, et al. Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology (Oxford). 2012;51:794–9.

    Article  CAS  Google Scholar 

  22. O’Hanlon TP, Rider LG, Schiffenbauer A, Targoff IN, Malley K, Pandey JP, et al. Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheumatol. 2008;58:3239–46.

    Article  Google Scholar 

  23. Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, Fertig N, et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheumatol. 2008;58:3247–54.

    Article  CAS  Google Scholar 

  24. Sugiura T, Kawaguchi Y, Goto K, Hayashi Y, Tsuburaya R, Furuya T, et al. Positive association between STAT4 polymorphisms and polymyositis/dermatomyositis in a Japanese population. Ann Rheum Dis. 2012;71:1646–50.

    Article  CAS  PubMed  Google Scholar 

  25. Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheumatol. 2013;65:3239–47.

    Article  CAS  Google Scholar 

  26. Hinds DA, McMahon G, Kiefer AK, Do CB, Eriksson N, Evans DM, et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet. 2013;45:907–11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM, et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet. 2011;7:e1002406.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.

    Article  CAS  PubMed  Google Scholar 

  30. Orens JB, Kazerooni EA, Martinez FJ, Curtis JL, Gross BH, Flint A, et al. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. Chest. 1995;108:109–15.

    CAS  PubMed  Google Scholar 

  31. Preliminary criteria for the classification of systemic sclerosis. (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheumatol. 1980;23:581–90.

    Article  Google Scholar 

  32. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol. 1997;40:1725.

    Article  CAS  Google Scholar 

  33. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol. 1988;31:315–24.

    Article  CAS  Google Scholar 

  34. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.

    Article  CAS  PubMed  Google Scholar 

  36. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626–36.

    Article  PubMed  Google Scholar 

  37. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38:209–13.

    Article  CAS  PubMed  Google Scholar 

  38. Barrett JC. Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc. 2009;2009:p71.

    Article  Google Scholar 

  39. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149–50.

    Article  CAS  PubMed  Google Scholar 

  40. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: Design and analysis issues. Mutat Res. 2005;573:54–69.

    Article  CAS  PubMed  Google Scholar 

  41. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA. 2011;305:183–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Jani M, Massey J, Wedderburn LR, Vencovsky J, Danko K, Lundberg IE, et al. Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. Ann Rheum Dis. 2014;73:1750–2.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Lin X, Varnai P, Csordas G, Balla A, Nagai T, Miyawaki A, et al. Control of calcium signal propagation to the mitochondria by inositol 1,4,5-trisphosphate-binding proteins. J Biol Chem. 2005;280:12820–32.

    Article  CAS  PubMed  Google Scholar 

  44. Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol. 2002;213:1–47.

    Article  CAS  PubMed  Google Scholar 

  45. Kanematsu T, Fujii M, Mizokami A, Kittler JT, Nabekura J, Moss SJ, et al. Phospholipase C-related inactive protein is implicated in the constitutive internalization of GABAA receptors mediated by clathrin and AP2 adaptor complex. J Neurochem. 2007;101:898–905.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to give our sincere appreciation and thanks to all the patients with PM/DM, who made this study possible, to Chunwei Cao for the useful suggestion he offered, and to Yang Du for the expertise and technical assistance.

Funding

This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health (201202004), and the National Natural Science Foundation of China Grants (81172857, 81373188), the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants (2011AA02A113), the National Science Technology Pillar Program in the 12th Five-year Plan (2014BAI07B00), and the Capital Health Research and Development of Special (2014-1-4011).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yongzhe Li.

Ethics declarations

The study was approved by the Ethics Committee of the Peking Union Medical College Hospital.

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Qian Wang, Si Chen, and Yuan Li have contributed equally to this manuscript.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 526 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Q., Chen, S., Li, Y. et al. Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han. Immunol Res 64, 204–212 (2016). https://doi.org/10.1007/s12026-015-8738-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-015-8738-x

Keywords

Navigation